logo
They Inhaled a Gas and Scaled Everest in Days. Is It the Future of Mountaineering?

They Inhaled a Gas and Scaled Everest in Days. Is It the Future of Mountaineering?

New York Times27-05-2025
Climbing Mount Everest typically takes weeks, with most of that time spent at the foot of the mountain adjusting to the thin air. But four British men last week shrank that timeline dramatically, traveling from London to the summit and back in less than a week, according to the organizer of their expedition.
They skipped the adjustment period, in part, by inhaling a secret weapon: xenon gas.
Their feat has roiled the world of mountaineering and prompted an investigation by the Nepalese government, as use of the gas is fiercely debated. Some research has shown that xenon can quickly acclimatize people to high altitudes, even as some experts say the benefits, if any, are negligible and the side effects of its use remain unclear.
Organizers said the gas was key to the speed of the climb, but their approach has prompted a broader debate that strikes at the core of mountaineering: Should scaling Mount Everest, one of sporting's greatest accomplishments, be made easier — available to more people during a quick vacation — with the help of a performance enhancer?
'It is a provocation, especially for traditional mountaineers, who feel bad about this idea that you can climb Everest in less than a week,' Lukas Furtenbach, who organized the exhibition, said in a phone interview from the base of the mountain. 'This showed that it can work.'
Mr. Furtenbach said that beginning in 2026 he planned to offer two-week round-trip excursions to Mount Everest using xenon gas, cutting the typical time needed to scale the mountain by several weeks.
'This can be the future of commercially guided mountaineering on Mount Everest,' he said.
With Xenon, 'you feel better.'
For those who live at lower elevations and have traveled to the mountains, the discomfort of altitude sickness is all too clear. Symptoms include nausea, headaches and disrupted sleep, and in some cases it can lead to brain swelling, or even death.
As you go higher, less oxygen is absorbed into the bloodstream with each breath. That is why so many people who climb Everest use supplemental oxygen.
Xenon, an odorless gas, has been known for years to activate a molecule called the hypoxia-inducible factor, which is also turned on when people acclimate to low oxygen, said Hugh Montgomery, a professor of intensive care medicine at University College London and a mountaineer who led an expedition to Mount Everest to study how humans respond to low oxygen.
'So what these people claim to have done,' he said, 'is basically found a way to switch on the adaptation to low oxygen levels.'
The group took what was known from medical science, he said, 'and have now applied it, recreationally, to sport mountaineering.'
Professor Montgomery said scientists were still unsure how xenon triggers this response.
While some doctors have used the gas in the past to 'precondition' patients to low oxygen levels — for example, before major heart surgery — the practice hasn't really caught on because 'it hasn't been as protective as one would hope,' he said.
Mike Shattock, a professor of cellular cardiology at King's College London, said 'xenon probably does very little and there is virtually no reputable scientific evidence that it makes any difference.'
Experts also cautioned that self-medicating with xenon, which has the effects of anesthesia, could lead to overdose or death, and more study was needed to understand how the gas works and its use in mountaineering.
On Mount Everest, the weeks of training and acclimation on the lower levels of the mountain are typically required to survive the 'death zone,' the area above 26,000 feet where the air is particularly thin.
The British group, which included four former special forces members, took a different approach.
About 10 weeks before the expedition, the men began sleeping in hypoxic tents, which lower oxygen levels in the air and gradually acclimatized the hikers to conditions on Mount Everest, Mr. Furtenbach said.
While hypoxic tents have been used by some climbers for years, the big innovation for the British expedition came two weeks before the excursion, when the men flew to Limburg, Germany, outside Frankfurt, where a doctor, Michael Fries, had been experimenting with inhaled gases in his clinic.
The men wore masks hooked up to ventilators as an anesthesiologist slowly introduced higher levels of xenon into their systems.
Mr. Furtenbach, who has tried xenon gas on his own mountaineering trips since 2020, said that after the treatment, users experienced enhanced breathing and the sensation of more lung volume, and 'when you do your workout or training, you feel better.'
After arriving at the base of Everest, the British group climbed to the summit in less than three days, which Mr. Furtenbach said was one of the fastest times for a group that hadn't acclimatized on the mountain. (According to the Nepalese government, the record for the fastest climb overall is held by Lakpa Gelu, a Sherpa, who reached the top of the mountain in just under 11 hours.)
The rapid climb by the British expedition and the use of the gas caught the eye of the Nepalese government, and the fallout has been swift.
The use of the gas is 'against climbing ethics.'
Himal Gautam, the director of Nepal's tourism department, which is responsible for regulating expeditions on the nation's mountains, said in an interview that using the gas was 'against climbing ethics,' and that it would hurt the country's tourism industry and the Sherpas who help climbers by reducing their time on the mountain.
Mr. Gautam said his department was looking into the use of the gas by the British climbers, one of whom, Alistair Carns, is also a member of Parliament.
In an interview, Mr. Carns said that his expedition has been in touch with the ministry, and clarified with the department that it had not taken the gas on the mountain.
He added that many people who want to climb Mount Everest don't have the time to spend multiple weeks acclimating.
'The reality is if I had six to eight weeks to climb Everest, I would, but I'm a government minister and I don't have time,' he said. 'What we've done is we've proven that you can reduce the timeline safely.'
Others in the mountaineering community have warned against the use of the gas.
In January, the International Climbing and Mountaineering Federation, a global network that promotes and protects the sport, released a statement that said there was no evidence that xenon gas improved performance, adding that 'inappropriate use can be dangerous.'
The federation noted that xenon has been on the World Anti-Doping Agency's list of banned substances since 2014 and is not approved in all countries.
'From a medical point of view, off-label use without a scientific basis and with unknown health risks must be rejected,' the statement said.
Mr. Furtenbach argued that his expeditions were still using Sherpas — five accompanied the British climbers to the summit — and that shorter times on the mountain were safer, as they reduce the chance that climbers will be exposed to other health threats, including avalanches, hypothermia or falls.
He said the prohibition of the gas by the World Anti-Doping Agency didn't apply to mountaineering because it is not a regulated competitive sport.
Use of the gas gets at a core question about why people climb big hills in the first place, Professor Montgomery said.
'Is it really a good idea that we can all have what we want, when we want, as quick as we want?' he asked. 'Are we missing out on the sacrifice you sometimes have to make to get the achievement?'
'I'm not a critic,' he added. 'But maybe just bagging every hill at speed means you miss out on the joy you could have had.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aging Can Spread Through Your Body Via a Single Protein, Study Finds
Aging Can Spread Through Your Body Via a Single Protein, Study Finds

Yahoo

timean hour ago

  • Yahoo

Aging Can Spread Through Your Body Via a Single Protein, Study Finds

Take note of the name: ReHMGB1. A new study pinpoints this protein as being able to spread the wear and tear that comes with time as it quietly travels through the bloodstream. This adds significantly to our understanding of aging. Short for reduced high mobility group box 1, ReHMGB1 triggers senescence in cells, permanently disabling them. It doesn't just do this locally; it can send damaging signals throughout the body, particularly in response to injuries or disease. "An important question in aging research is why senescent cells increase with age," write the study authors, led by researchers from the Korea University College of Medicine. Related: The team says their findings could help develop ways to keep us healthier for longer. If we can block or control this protein's signals, it might slow the cascade of cellular decline that comes with age. "This study reveals that aging signals are not confined to individual cells but can be systemically transmitted via the blood, with ReHMGB1 acting as a key driver," says Korea University biomedical engineer Ok Hee Jeon. The researchers were able to identify ReHMGB1 as a critical messenger passing on the senescence signal by analyzing different types of human cells grown in the lab and conducting a variety of tests on mice. When ReHMGB1 transmission was blocked in mice with muscle injuries, muscle regeneration happened more quickly, while the animals showed improved physical performance, fewer signs of cellular aging, and reduced systemic inflammation. The next step would be to see how this process could be disrupted, and this particular type of aging signal kept more localized – so the health conditions that come with old age might not be as damaging. "By blocking this pathway, we were able to restore tissue regenerative capacity, suggesting a promising strategy to treat aging-related diseases," says Jeon. This process is only one contributor to aging out of many, but the signals that ReHMGB1 spreads are particularly important in terms of our bodies becoming dysfunctional over time and less able to carry out repairs. It's also worth bearing in mind the useful functions of ReHMGB1 in the body: alerting our biological systems to damage and indicating that repairs are needed. Any kind of intervention will have to take that into consideration. We know that, generally speaking, populations are living for longer than ever before, and that's putting both our bodies and scientific research into uncharted territory. The various routines built into our cells must continue to function when years ago our bodies would have long given up. Related: From where we live to the genetics we're born with, there are many contributors to aging and lifespan. By learning more about how these work, we'll be better able to manage them – and perhaps extend life further. "Building on current research in these areas will be essential to understanding the therapeutic potential of redox-sensitive HMGB1 in aging-related diseases and its role as a systemic mediator of senescence," write the researchers in their published paper. The research has been published in Metabolism. Related News New Genetic Test Predicts Children With Future Risk of High BMI This Diet Helps Lower Dementia Risk, And We May Finally Know Why A Signal of Future Alzheimer's Could Hide in The Way You Speak Solve the daily Crossword

Why the U.S. and China Are Playing Nice
Why the U.S. and China Are Playing Nice

Yahoo

timean hour ago

  • Yahoo

Why the U.S. and China Are Playing Nice

Credit - Getty Images The U.S. and the People's Republic of China are strategic rivals in the battle for global leadership in the 21st century. So it was no surprise when President Donald Trump hit China with 20% tariffs in the first few weeks of his second term and then imposed reciprocal tariffs of 34% on 'Liberation Day.' And when Trump a few days later lowered tariff rates for everyone else to calm markets, he quadrupled duties on China to a whopping 145%. But all that now feels like ancient history. Over the past four months, Trump has bent over backwards to be kind to Beijing. The two sides announced a 90-day ceasefire in Geneva in early May, agreeing to reduce tariffs and negotiate their differences over export controls and other issues. (Remaining U.S. tariffs on China are still at roughly 55%, and China's tariffs on the U.S. stand at almost 33%. These are historically high levels, but not sufficient to outright stop trade.) Further discussions in London and Stockholm made enough progress for the two sides this week to announce another extension of the ceasefire, with the White House praising Beijing for being cooperative and flexible in the negotiations to date. Read More: Why Trump Will Blink First on China In the same vein, the Trump Administration has not shut down TikTok in the U.S. despite the fact that it is still Chinese-controlled, in contravention of American law; it denied a transit visa for Taiwanese President William Lai; and it is allowing Nvidia and AMD to sell advanced chips in China despite originally blocking many of these sales, following a pay-for-play deal. So why the sudden about-face on China? It is doubly odd given the U.S.'s simultaneous tough tact toward other members of the BRICS—a rival to the U.S.-led G7 that includes Brazil, Russia, India, and South Africa—not to mention many of America's traditional allies. Three reasons stand out. First, both Washington and Beijing now have proven weapons that are restraining the aggressive instincts of the other side. Unlike others who caved in to Trump's pressure, Beijing retaliated, first with its own high tariffs, and then, more importantly, with restrictions on rare earth minerals, over which they have a global chokehold. Once Trump began lowering most of the initial reciprocal tariffs and calling for talks with Xi, they had confidence that restricting rare earths minerals and magnets would be met not with counterstrikes but with concessions. That includes the Trump Administration backing off imposing new export controls on several technologies and scrapping their threat to 'aggressively revoke' Chinese student visas. Beijing now believes it has perfected the recipe for making a 'TACO' ('Trump always chickens out'). Second, Trump and Xi both have an interest in strengthening economic confidence at home. With persistent overcapacity and price wars across industrial and consumer sectors, 'involution' has become the word of the year in China, a nod to the excessive competition that is hurting local businesses. Xi needs to shore up government finances, consolidate industries, and avoid further international barriers to Chinese exports and investment. The U.S.'s current economic picture is stronger, but constituents in town halls across the country have expressed deep worries about lost export markets, inflation, budget deficits, and a potential recession. Third, both Trump and Xi want to meet each other, most likely in the Fall in Asia. Trump has been signaling his desire for direct communication with Xi since at least April. He wants to assemble a deal that he can sell at home as boosting U.S. business opportunities and stopping the fentanyl epidemic, given China's role in producing most of the precursors in the synthetic opiod that is trafficked to America. The Chinese have played hard to get, privately saying any summit must be preceded by detailed negotiations and planning. Based on my conversations with experts in China in recent weeks, Xi wants to avoid being disrespected, as Ukrainian President Zelensky and other world leaders were during their White House visits. And with Trump making concession after concession, Beijing may want to consolidate its recent gains and aim even higher, perhaps inducing Trump to make further compromises over tariffs, export controls, and Taiwan. Read More: It's Time for Trump and Xi to Meet Although one should not dismiss the value of stable ties between the world's two largest economies, each equipped with massive stockpiles of nuclear weapons, this warming trend is unlikely to last very long. Both sides prefer calmness now because it aligns with their short-term interests. Chinese official rhetoric aside, neither side sees the relationship in cooperative terms, and neither is willing to take major steps to provide strategic reassurance to the other. The underlying fundamental challenges created by the countries' deep divisions over their economic ties, the potential for conflict over Taiwan and other hotspots, and their competing visions of the international order can only be papered over for so long. At some point Beijing may run out of luck, and either not concede enough in negotiations or push too hard to make a TACO, and instead generate a Trumpian tirade or policy overreaction. Trump's unpredictability make linear extrapolations of any U.S. policy or strategy a risky bet. At some point, for either reasons of policy or fashion, the U.S.'s current gentle approach toward Beijing is likely to eventually harden, and for a new scene in the drama to unfold. Read More: Why China Can't Win a Trade War Beijing knows no deal with Trump is permanent. They will enjoy the peace and quiet as long as they can, but they know they need to be prepared for the next round of escalation—whenever it arrives. Other countries, companies, and markets should, too. Contact us at letters@ Solve the daily Crossword

Is India committing a blunder by siding with Russia?
Is India committing a blunder by siding with Russia?

Yahoo

time2 hours ago

  • Yahoo

Is India committing a blunder by siding with Russia?

-- In a note this week, analysts at Bernstein questioned whether India is 'committing a blunder by siding with Russia,' warning that shifting geopolitical alignments could have 'a significant impact on the India story.' The firm stated that while the recently imposed 50% U.S. tariff on Indian goods 'is in our view the least of the country's worries,' the 'sudden shift in tone and engagement' between Washington and New Delhi is seen as more concerning. The firm stated that U.S. President Donald Trump has 'singled out India for Russian oil purchases,' prompting India to respond firmly, calling U.S. actions 'unjust and unreasonable' and openly defending its trade with Russia. Bernstein highlighted that trade talks now appear 'suspended' and that India seems 'unfazed,' even as reports circulate about Prime Minister Narendra Modi's planned visit to China and a potential visit by Russian President Vladimir Putin. Recalling recent optimism, Bernstein said that as recently as February, talk of doubling U.S.-India trade to $500 billion and reaching a deal by fall 2025 had cheered investors. But instead of reduced tariffs, India now faces '25% (then 50%) tariffs.' The analysts stressed that 'India's merchandise exports to U.S. are 18x that of Russia,' while Russian exports to India are 'fragmented' and largely energy-related. Oil discounts from Russia, they noted, are modest given the extra refining required, asking: 'Are these extra $2-3 really worth the diplomatic shift?' Bernstein concluded with a pointed question: 'Is it worth the risk to protect some industries while closing doors for all others to sell? Or it makes more sense to open up to a developed country, where export opportunities will always trump the incoming imports?' Related articles Is India committing a blunder by siding with Russia? Victoria's Secret Exposed: The Warning Sign Behind the Stock's 52% Collapse These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store